{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:56:04Z","timestamp":1792418164480,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>The aim of this study was to assess the histopathologic spectrum of renal tumors in patients with <jats:italic toggle=\"yes\">PTEN<\/jats:italic> hamartoma tumor syndrome (PHTS), with a specific focus on potential features predictive of the underlying syndrome. A multi-institutional study was conducted to obtain clinical and pathologic data on renal tumors arising in patients with PHTS, either diagnosed by germline mutational analysis or clinical criteria for Cowden syndrome. Histologic sections of the renal tumors were re-reviewed for classification. Twelve renal epithelial tumors from 9 patients were identified (4 males and 5 females, with a mean age of 41.8\u00a0y), 7 of whom carried germline <jats:italic toggle=\"yes\">PTEN<\/jats:italic> mutations. All 12 renal epithelial tumors were renal cell carcinomas (RCCs): 5 were chromophobe RCCs, 4 papillary RCCs, and 3 RCC not otherwise specified. Pathologic stage distribution was: 7 (59%) pT1a, 2 (17%) pT1b, 1 (8%) pT2a, 1 (8%) pT2b, and 1 (8%) pT3a. World Health Organization\/International Society of Urological Pathology (WHO\/ISUP) histologic grade was applicable in 7 (54%) nonchromophobe tumors: 4 (57%) G2, 2 (29%) G3, and 1 (14%) G4. An unexpected histologic finding was the presence of 2 patients with incidental microscopic collections of intrarenal adipocytes that had no features of angiomyolipoma (and were negative with 2 sensitive PEComa markers: cathepsin-K and GPNMB); both were classified as lipoma\/\u201clipomatous hamartomas.\u201d The average follow-up interval was 67.8 months (13 to 172\u00a0mo): 5 patients had no evidence of disease, 2 were lost to follow-up, 1 died of other (non-PHTS) causes (ie, prostate cancer), and 1 was alive with metastatic RCC to the lung (RCC not otherwise specified with rhabdoid differentiation). All tumors showed loss of nuclear PTEN staining by immunohistochemistry. Fumarate hydratase was retained and 2SC was negative in all papillary RCCs. CK7 was moderate-strong\/diffuse positive in 4 of 5 chromophobe RCCs and in 3 of 4 papillary RCCs. Renal epithelial tumors associated with PHTS represent a heterogeneous group of RCCs, but classic chromophobe and papillary RCC are most common. The majority have a favorable clinical behavior as would be predicted by subtype. In contrast to other hereditary renal neoplasia syndromes, morphologic features of the RCCs do not allow identification of PHTS-associated neoplasia with any degree of specificity in the absence of clinical setting and\/or prior history, but the presence of microscopic \u201clipomas\u201d within the kidney may provide a clue in rare cases. Therefore, clinical suspicion and genetic counseling with germline testing remain necessary for identifying PHTS-associated RCC.<\/jats:p>","DOI":"10.1097\/pas.0000000000002079","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T11:02:12Z","timestamp":1687777332000},"page":"1001-1010","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome"],"prefix":"10.1097","volume":"47","author":[{"given":"Diana","family":"Kozman","sequence":"first","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Sui","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford Medical Center, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Urology, and Massey Cancer Center, VCU School of Medicine"},{"name":"Richmond VA Medical Center, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Kehr","sequence":"additional","affiliation":[{"name":"CellNetix Pathology and Laboratories, Tacoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tretiakova","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Przybycin","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Eng","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-5032","authenticated-orcid":false,"given":"Reza","family":"Alaghehbandan","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"PTEN: one gene, many syndromes","volume":"22","author":"Eng","year":"2003","journal-title":"Hum Mutat"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-58-1-136","article-title":"Cowden\u2019s disease. A possible new symptom complex with multiple system involvement","volume":"58","author":"Lloyd","year":"1963","journal-title":"Ann Intern Med"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"e2200415","DOI":"10.1200\/PO.22.00415","article-title":"Cancer risk associated with PTEN pathogenic variants identified using multigene hereditary cancer panel testing","volume":"7","author":"Cummings","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1187.e1","DOI":"10.1016\/j.urology.2011.12.025","article-title":"Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome","volume":"79","author":"Mester","year":"2012","journal-title":"Urology"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.juro.2013.06.012","article-title":"Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer","volume":"190","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41525-020-00148-7","article-title":"Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome","volume":"5","author":"Kim","year":"2020","journal-title":"NPJ Genom Med"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2020.11.024","article-title":"PTEN hamartoma tumor syndrome: a case of renal cell carcinoma in a young female","volume":"148","author":"Ramkumar","year":"2021","journal-title":"Urology"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PAP.0000000000000349","article-title":"The histologic diversity of chromophobe renal cell carcinoma with emphasis on challenges encountered in daily practice","volume":"29","author":"Alaghehbandan","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAS.0000000000001802","article-title":"Papillary renal cell carcinoma with microcystic architecture is strongly associated with extrarenal invasion and metastatic disease","volume":"46","author":"Chan","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/PAS.0000000000000639","article-title":"Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma?","volume":"40","author":"Hes","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/PAS.0000000000001680","article-title":"Distal tubular hyperplasia: a proposal for a unique form of renal tubular proliferation distinct from papillary adenoma","volume":"45","author":"Williamson","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real Cowden syndrome please stand up: revised diagnostic criteria","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fgene.2018.00353","article-title":"Early onset multiple primary tumors in atypical presentation of Cowden syndrome identified by whole-exome-sequencing","volume":"9","author":"Cavaill\u00e9","year":"2018","journal-title":"Front Genet"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13256-018-1863-0","article-title":"A family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report","volume":"12","author":"Gruhl","year":"2018","journal-title":"J Med Case Rep"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.mayocp.2020.09.016","article-title":"Renal neoplasia in Cowden syndrome","volume":"95","author":"Gupta","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/archdischild-2014-305997","article-title":"PTEN hamartoma tumour syndrome: early tumour development in children","volume":"100","author":"Smpokou","year":"2015","journal-title":"Arch Dis Child"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/PAP.0b013e318299b7c6","article-title":"Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens","volume":"20","author":"Przybycin","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","article-title":"Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience","volume":"23","author":"Patard","year":"2005","journal-title":"J Clin Oncol"},{"key":"R21-20250608","first-page":"3841","article-title":"Somatic mutation and homozygous deletion of PTEN\/MMAC1 gene of 10q23 in renal cell carcinoma","volume":"19","author":"Alimov","year":"1999","journal-title":"Anticancer Res"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-4608(01)00413-7","article-title":"Allelic loss at 10q23.3 but lack of mutation of PTEN\/MMAC1 in chromophobe renal cell carcinoma","volume":"128","author":"Sukosd","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/modpathol.3880551","article-title":"Intragenic PTEN\/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis","volume":"15","author":"Velickovic","year":"2002","journal-title":"Mod Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"151978","DOI":"10.1016\/j.anndiagpath.2022.151978","article-title":"Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: a comparative international multi-institutional study","volume":"60","author":"Kolar","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"313.e5","DOI":"10.1016\/j.celrep.2018.06.032","article-title":"The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"e0179610","DOI":"10.1371\/journal.pone.0179610","article-title":"The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: a retrospective study of tissue microarrays using immunohistochemistry","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"e0179437","DOI":"10.1371\/journal.pone.0179437","article-title":"Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: a systematic review and meta-analysis","volume":"12","author":"Tang","year":"2017","journal-title":"PLoS One"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/ijc.32579","article-title":"PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma","volume":"146","author":"Roldan-Romero","year":"2020","journal-title":"Int J Cancer"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41401-022-00862-1","article-title":"PTEN loss confers sensitivity to rapalogs in clear cell renal cell carcinoma","volume":"43","author":"Liu","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e31824dd86c","article-title":"PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes","volume":"36","author":"Kurek","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:42Z","timestamp":1749416442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002079"}},"subtitle":["Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal \u201cLipomas\u201d"],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002079","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,26]]}}}